ArticleUnited European gastroenterology journal2024

Efficacy, safety and differential outcomes of immune-chemotherapy with gemcitabine, cisplatin and durvalumab in patients with biliary tract cancers: A multicenter real world cohort.

Katharina Mitzlaff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.